Myocarditis News and Research

RSS

In medicine (cardiology), myocarditis is inflammation of heart muscle (myocardium). It resembles a heart attack but coronary arteries are not blocked.

Philippines starts vaccinating children aged five to 11 against COVID-19

The Philippines began vaccinating children aged five to 11 against COVID-19 on Monday after initial hiccups over delayed deliveries of the Pfizer-BioNTech doses and opposition to the drive by some parents.

9 Feb 2022

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Researchers estimated the risk and one-year burden of a set of pre-specified cardiovascular outcomes in a cohort of COVID-19-infected patients who survived the acute phase of illness.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

Red foxes susceptible to SARS-CoV-2 infection

Working towards the aim to determine the SARS-CoV-2 susceptibility of common wildlife species, the researchers in the United States have found that red fox (Vulpes vulpes) can experimentally become infected with SARS-CoV-2 and can shed virus in its oral and nasal secretions.

3 Feb 2022

Artificial intelligence could help better predict the onset and course of cardiovascular disease

For the first time, University of Utah Health scientists have shown that artificial intelligence could lead to better ways to predict the onset and course of cardiovascular disease.

25 Jan 2022

AI could lead to better ways to predict the onset and course of cardiovascular disease

For the first time, University of Utah Health scientists have shown that artificial intelligence could lead to better ways to predict the onset and course of cardiovascular disease.

20 Jan 2022

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

In a new study, researchers used bioinformatics tools to explore the biological characteristics of SARS-CoV-2-infected myocardium.

19 Jan 2022

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

In a new study, a team of researchers described the case of a healthy 49-year old male patient with new-onset atrial fibrillation after receiving the second dose of the COVID-19 mRNA-1273 (Moderna) vaccine.

19 Jan 2022

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours — a feat that's nearly unheard of in standard clinical care.

19 Jan 2022

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

In a new study, a team of researchers estimated the pre-pandemic incidence rates of adverse events of special interest now observed in association with COVID-19 vaccines in Canada.

18 Jan 2022

As omicron surges, effort to vaccinate young children stalls

Two months after Pfizer's covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million kids, have both doses.

15 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours - a feat that's nearly unheard of in standard clinical care.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

Myocarditis News and Research

Further Reading

Philippines starts vaccinating children aged five to 11 against COVID-19

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Red foxes susceptible to SARS-CoV-2 infection

Artificial intelligence could help better predict the onset and course of cardiovascular disease

AI could lead to better ways to predict the onset and course of cardiovascular disease

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

As omicron surges, effort to vaccinate young children stalls

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

International study offers a clearer picture of COVID-19's impact on children

Mathematical modeling the vaccination of children against SARS-CoV-2

Oral bacteria-based SARS-CoV-2 vaccine platform

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

COVID-19 vaccine appears safe in children aged 5–11 Years

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News